5 completed. 5 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
| Phase 1 | 1 | Completed 1 |
Follow ForSight Vision5, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular Hypertension Fixed Combination, Bimatoprost, Timolol - Open-Angle Glaucoma, Ocular Hypertension | Phase 1 / Phase 2 | Completed | ForSight Vision5, Inc. | 55 | 2016-04-30 | 2019-02-25 |
| An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert Bimatoprost - Primary Open-Angle Glaucoma, Ocular Hypertension | Phase 2 | Completed | ForSight Vision5, Inc. | 81 | 2015-08-10 | 2019-04-02 |
| Dose-Ranging Study of the Bimatoprost Ocular Insert Bimatoprost, Timolol 0.5%, Placebo Ocular Insert - Primary Open-Angle Glaucoma, Ocular Hypertension | Phase 2 | Completed | ForSight Vision5, Inc. | 156 | 2015-01-19 | 2020-06-04 |
| An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product Bimatoprost - Primary Open-Angle Glaucoma, Ocular Hypertension | Phase 2 | Completed | ForSight Vision5, Inc. | 75 | 2014-06-05 | 2019-02-26 |
| Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension Bimatoprost, Timolol 0.5%, Placebo Eye Drops - Primary Open-Angle Glaucoma, Ocular Hypertension | Phase 2 | Completed | ForSight Vision5, Inc. | 169 | 2013-10-23 | 2018-04-20 |
Glaucoma, Open-Angle (5) · Ocular Hypertension (5) · Glaucoma (1)
Bimatoprost (5) · Timolol (2)
United States (4) · Panama (1)